Reading Time: 8 minutesFollowing on from our previous catch-up blog on clinical management talks presented at the Symposium, here is a continuation that looks at talks focusing on
Search Results for: clinical trial
Reading Time: 3 minutesIt was only one week after the 27th International Symposium on ALS/MND in Dublin had ended when we started the next stage of planning for
Reading Time: 2 minutesIn their official press release published on 21 November 2017, Cytokinetics Inc. announced that they will not be continuing work on tirasemtiv after disappointing results
Reading Time: 3 minutesAs I settle into my role as the Research Programmes and Partnerships Manager with the MND Association, I would like to take the opportunity to
Reading Time: 3 minutesAt last year’s Airlie House workshop to develop new ALS/MND Clinical Trial Guidelines the focus was, of course, on MND, but there was also important input
Causes and disease mechanisms Clinical Trials Markers of Disease Progression MND Research Research we fund
Lighthouse Project shines a beacon on HERVs and their role in ALS
Reading Time: 3 minutesThere is recent evidence to suggest that Human Endogenous Retroviruses (HERVs) may be involved in amyotrophic lateral sclerosis (ALS). HERV-K has been directly linked to
Reading Time: 4 minutesConferences and symposia are a crucial part of the research world – not only for the amount of knowledge that is communicated to large audiences
Reading Time: 5 minutesIt’s been over a month since the announcement by the FDA of their decision to licence edaravone / Radicava for people with MND in the
Reading Time: 3 minutes21 June – MND Awareness Day Each year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on
Reading Time: 4 minutesEach year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on the eyes – in most people